Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication

Pack, Alison; Oskoui, Maryam; Williams Roberson, Shawniqua; Donley, Diane; A. French, Jacqueline; E. Gerard, Elizabeth; Gloss, David; R. Miller, Wendy; M. Munger Clary, Heidi; S. Osmundson, Sarah; McFadden, Brandy; Parratt, Kaitlyn; B. Pennell, Page; R. Saade, George; B. Smith, Don; L. Sullivan, Kelly; V. Thomas, Sanjeev; Tomson, Torbjörn; Dolan O’Brien, Mary; Botchway-Doe, Kylie; M. Silsbee, Heather; R. Keezer, Mark

doi:10.1212/wnl.0000000000209279

Public

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication

Published in Neurology • May 15, 2024

Authors:

Alison Pack

Maryam Oskoui

Shawniqua Williams Roberson

Abstract

This practice guideline provides updated evidence-based conclusions and recommendations regarding the effects of antiseizure medications (ASMs) and folic acid supplementation on the prevalence of major congenital malformations (MCMs), adverse perinatal outcomes, and neurodevelopmental outcomes in ch...

Subject

In utero

Medicine

Pediatrics

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!